About the Journal

  1. Journal Title: Cermin Dunia Kedokteran
  2. Initials: CDK
  3. Frequency: monthly/year
  4. Online ISSN: 2503-2720
  5. TD-PSE (Kominfo): 003119.02/DJAI.PSE/07/2022
  6. DOI in Crossref: 10.55175
  7. Editor in Chief: Dr. dr. Budi Riyanto Wreksoatmodjo, Sp.N
  8. Publisher and Managed by: PT Kalbe Farma Tbk.
  9. Accreditation Number: No. 152/E/KPT/2023 (SINTA 4) Periode Akreditasi: Volume 48 Nomor 6 Tahun 2021 sampai Volume 53 Nomor 5 Tahun 2026  
Cermin Dunia Kedokteran (CDK) is a scientific medical journal focused on the development of medical science, pharmacy, and public health, oriented toward evidence-based practice, service innovation, and the integration of health policies in local, national, and global contexts.  Manuscripts are published under an open-access policy. Manuscripts undergo a double-blind peer review process; at least two reviewers will review manuscripts relevant to the topic of the manuscript. The journal is published monthly (January to December). The CDK Journal accepts research manuscripts, systematic review, meta-analyses, evidence-based case report, case report, and literature review.

Submitted manuscripts must be original (written by the authors themselves and not the result of plagiarism) and must not be simultaneously submitted to, under review by, or in the process of publication in another journal or conference. Articles that fall outside the scope of the CDK Journal will not be processed for publication. Please read and follow the author guidelines.

Currently, submissions to CDK are subject to a publication fee (IDR Rp500,000,-), payable in advance, for systematic reviews, meta-analyses, evidence-based case reports, literature reviews, and case reports; however, primary research manuscripts that are eligible for publication are exempt from the publication fee.

Articles involving foreign authors (authors from abroad or Indonesian authors affiliated with institutions abroad) will be exempt from fees, regardless of whether they are the first, second, or subsequent authors.
 

IMPORTANT NOTICE*

Effective October 5th, 2026, CDK Journal is temporarily not accepting new Literature Review submissions. We will still accept research articles, systematic reviews, meta-analyses, and case reports.

Literature Review manuscripts that have already been submitted will continue to be processed through the editorial and peer-review process.

*This information is valid until further notice

Current Issue

Vol. 53 No. 10 (2026): October 2026 - CDK 357
					View Vol. 53 No. 10 (2026): October 2026 - CDK 357
This issue features research articles on mesenchymal stem cells—a highly promising field with the potential for breakthroughs in treatment, particularly for degenerative diseases; issues that will become increasingly prominent as life expectancy rises, including among the Indonesian population. Combined with a discussion on monitoring kidney function, especially among the elderly, this issue is expected to broaden understanding of several geriatric health issues. Supplemented by an analysis of the impact of air pollution on the incidence of acne vulgaris, this issue addresses several health issues that will become increasingly important in the future.     Case reports cover topics ranging from bacterial resistance and preventable neonatal conjunctivitis to congenital anomalies and volvulus in the elderly—conditions that require vigilance. Additionally, this issue includes a case study on metastasis that requires integrated management.     The analysis of the Free Nutritious Food Program (MBG)—a crucial national program—is worth noting as input for future program improvements to achieve the program’s goal of improving the nutrition of future generations.  
Published: 15-10-2026

Articles

View All Issues